Peninsula Medical School: Recent submissions
Now showing items 111-120 of 1220
-
Assessment of patients with lower urinary tract symptoms where an undiagnosed neurological disease is suspected: A report from an International Continence Society consensus working group
(WileyUnited States, 2020-11)AimLower urinary tract symptoms (LUTS) are a common urological referral, which sometimes can have a neurological basis in a patient with no formally diagnosed neurological disease (“occult neurology”). Early identification ... -
An International Multi-Stakeholder Delphi Survey Study on the Design of Disease Modifying Parkinson’s Disease Trials
(IOS PressNetherlands, 2023-11-18)Background: Design of disease modification (DM) trials for Parkinson’s disease (PD) is challenging. Successful delivery requires a shared understanding of priorities and practicalities. Objective: To seek stakeholder ... -
A modular, deep learning-based holistic intent sensing system tested with Parkinson’s disease patients and controls
(Frontiers Media SASwitzerland, 2023-11-01)People living with mobility-limiting conditions such as Parkinson’s disease can struggle to physically complete intended tasks. Intent-sensing technology can measure and even predict these intended tasks, such that assistive ... -
Dementia screening in rural Kenya: The prevalence and impact of screening positive for dementia
(Karger PublishersSwitzerland, 2024-03-19)Introduction: In Kenya, there is a lack of data on the number of people with dementia. In this article, we aim to estimate the number of community-dwelling older adults (aged 60 years and above) that are potentially living ... -
Cell cycle control by cell-matrix interactions
(Elsevier BVEngland, 2024-02)Cell adhesion to the extracellular matrix (ECM) is required for normal cell cycle progression and accurate cell division. However, how cell adhesion to the wide range of ECM proteins found in human tissues influences the ... -
Author Correction: Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2)
(Springer Science and Business Media LLCUnited States, 2023-09-13)Correction to: s41531-023-00526-9 npj Parkinson’s Disease, published online 27 June 2023 In this article the Global Parkinson’s Genetics Program (GP2) members names and affiliations were missing in the main author list ... -
Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
(Springer Science and Business Media LLCUnited States, 2023-09-12)The Global Parkinson’s Genetics Program (GP2) will genotype over 150,000 participants from around the world, and integrate genetic and clinical data for use in large-scale analyses to dramatically expand our understanding ... -
Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study
(Springer Science and Business Media LLCNew Zealand, 2023-10-10)Correction: Neurol Ther https://doi.org/10.1007/s40120-023-00533-1 -
National study of NAFLD management identifies variation in delivery of care in the UK between 2019 to 2022
(Elsevier BVNetherlands, 2023-12)Background & Aims: Non-alcoholic fatty liver disease (NAFLD) is associated with liver and cardiovascular morbidity and mortality. Recently published NAFLD Quality Standards include 11 key performance indicators (KPIs) of ... -
Identification of druggable regulators of cell secretion via a kinome-wide screen and high-throughput immunomagnetic cell sorting
(Nature ResearchEngland, 2023-11-27)The identification of genetic regulators of cell secretions is challenging because it requires the sorting of a large number of cells according to their secretion patterns. Here we report the development and applicability ...